MSH2 and B-cell non-Hodgkin lymphoma: We prepared nuclear extracts from three human cell lines: HeLa, derived from an adenocarcinoma [22,32]; Ramos, derived from an actively hypermutating B cell lymphoma [33]; and LoVo, derived from an MSH2-deficient colorectal carcinoma [34].